CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards
CSL's Broadmeadows facility has been recognised as the Overall Winner of the 2025 Facility of the Year Award by the International Society for Pharmaceutical Engineering (ISPE).
The facility blends Pharma 4.0 principles with sustainable design to transform plasma manufacturing, setting new standards in responsible innovation.
Purpose-built to optimise the production of plasma-derived therapies, the Broadmeadows facility combines cutting-edge technologies with a pioneering hybrid manufacturing platform.
CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering (ISPE).
Author's summary: CSL wins 2025 Facility of the Year Award.
More News
- Despite predictions, voters support Javier Milei
- Stockton strikes again as resilient Magpies climb to sixth after Portishead win
- Kratom: What You Need to Know About This “Natural” Opioid
- RRH launches free genetic screening program
- DJ Carey Sentenced for Fraud
- Knickerbocker Theatre to Host Four Humphrey Bogart Films Beginning Nov. 10
- Kimberly-Clark to Acquire Kenvue, Creating a $32B Global Health and Wellness Leader
- Kimberly-Clark to Acquire Tylenol Maker Kenvue in $48.7 Billion Deal, Creating Global Consumer Health Giant
- Was data mesh just a fad?
- Knickerbocker to Host Special Screening of “The Most Precious of Cargoes” Nov. 13–14